Breakthrough in Aesthetic Medicine: CHANDO Unveils Epigenetic Skincare at IMCAS
Published on: Feb. 7, 2026, 11:44 a.m. | Source: Devdiscourse
The IMCAS World Congress 2026 spotlighted CHANDO's innovative skincare research through the presentation of a novel epigenetic pathway. The study highlighted the 4-Butylresorcinol (577) Pigment Management Mechanism, showcasing its potential in targeted skin brightening and its relevance to Asian skin types.
